Alnylam Pharmaceuticals, Inc. (ALNY) Price Prediction & ForecastALNYAlnylam Pharmaceuticals, Inc.

Alphio's ALNY stock price prediction model matches the current Alnylam Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $233.66 (-1.45%). The 1-week path is $248.79 (+4.93%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Alnylam Pharmaceuticals Inc is currently a hold. The stock is trading at $237.10, which is above the Fibonacci Pivot level of $233.68, indicating some short-term support. However, the stock has seen a significant decline of 40.75% year-to-date and 46.96% over the past year, raising concerns about its stability. The RSI is at 54.77, suggesting it is neither overbought nor oversold, which aligns with a cautious approach. The forward P/E ratio is 27.55, indicating that the stock is relatively expensive compared to its expected earnings growth. Analyst ratings vary, with a price target range from $230 to $455, showing mixed sentiment. The main risk is the recent negative trial results impacting its ATTR drug business, which could further pressure the stock.

Alnylam Pharmaceuticals, Inc. (ALNY) last closed at $237.1, gaining +0.23%. These facts feed the 1-day and 1-week ALNY price prediction above.